Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
The First Line of Therapy in Severe Migraine Attacks More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal carbonates and bicarbonates and particular flavouring substances. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2008 - 180 pages - $3,500
Mar 2011 - 23 pages - $5,700
Sep 2008 - $2,500
Nov 2010 - 40 pages - $500
Nov 2010 - 50 pages - $2,000
Oct 2010 - 169 pages - $3,500
Nov 2010 - 1168 pages - $1,495
Dec 2010 - 84 pages - $500
Oct 2011 - 131 pages - $3,500
Your selection
Browse By
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us